Nifty 50
- Dr. Reddy's Labs₹1,310.9081.40 (6.62%)
- Shriram Finance₹825-40.00 (-4.62%)
- JSW Steel₹1,26074.50 (6.28%)
- Tata Consumer ₹936.50-27.40 (-2.84%)
- BSE₹3,359128.20 (3.97%)
- Bajaj Finance₹918.70-10.25 (-1.10%)
- Adani Ports₹1,752.5049.80 (2.92%)
- HDFC Life Insurance ₹519-4.75 (-0.91%)
- Eternal₹325.558.15 (2.57%)
- HDFC Bank₹688.05-4.75 (-0.69%)
- Max Healthcare₹83520.00 (2.45%)
- Sun Pharmaceutical₹1,740-8.00 (-0.46%)
- Kotak Mahindra Bank₹440.7510.25 (2.38%)
- HCL Technologies₹1,417-5.20 (-0.37%)
- Grasim Industries₹2,95056.00 (1.94%)
- Tata Motors PV₹263.70-0.90 (-0.34%)
- Coal India₹4057.55 (1.90%)
- Mahindra & Mahindra₹2,853.10-8.10 (-0.28%)
- Hindalco Industries₹885.6515.80 (1.82%)
- Power Grid Corp₹247-0.40 (-0.16%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Aditya Birla Lifestyle Brands: Recovery Remains Steady; Maintain BUY
Authored By Prime Research | Last Modified: Mar 25, 2026 02:19 PM IST

Open Free Demat Account
Open Free Demat Account
ABLBL’s recovery across segments remains steady. Weeding off unprofitable stores seems largely behind in Lifestyle brands (LB), and early signs of a pick- up in expansion are visible (59 net stores in Q3FY26 vs a muted H1FY26). Channel checks suggest demand till mid-February remained healthy, post which a moderation was witnessed. Online/MBO channels are expected to outpace Retail in Q4. However, as expansion picks up in FY27 (300-350 gross/200-250 net adds), Retail channel should mean-revert to double-digit growth, in our view. We expect mid-single-digit SSSG over FY26-28. We pencil an 80bps improvement in LB EBITDAM (on a low base) to 9.8% in FY28. In emerging brands (EB), the F21 drag is now behind and from here on, we expect EB (AE, VH Innerwear and Reebok) to grow at >20% over FY26-28 with EBITDAM expanding from near break-even to ~4.5%. We maintain our FY27/28 EBITDA estimates and our BUY rating with an SOTP-based TP of INR155/sh (implying ~20x FY28 EV/EBITDA). Note: At CMP, the stock is trading at ~12x FY28 EV/EBITDA (pre-IND-AS 116).
Lifestyle brands recovery remains steady: Channel checks suggest demand momentum until mid-February was healthy, post which some moderation was witnessed. EOS sales remained healthy. While there are signs of Retail channel recovery (as expansion has picked up), Online/MBO channels are expected to outpace Retail in Q4. We expect store expansion to pick up decisively in FY27 (management expects to achieve 250 net adds vs HSIE: 170 stores). This, coupled with mid-single-digit SSSG, is likely to ensure low-double-digit growth in LB in FY27.
F21 drag in Emerging Brands (EB) is now behind: The EB portfolio (comprising American Eagle, Reebok, and VH Innerwear) now seems to be at an inflection point in terms of growth and margins. The introduction of lower price points (per channel checks) has helped induce traction across MBOs for innerwear products. The F21 drag in EB is now behind. Hence, the EB portfolio now seems to be well placed to spur growth while improving margins. We pencil in >20% revenue growth over FY26-28 with EBITDAM expanding from near break-even to ~4.5%.
Risk-reward favorable: Most of the pain points in the portfolio have been churned out and now it is all about execution. The ask from core – Lifestyle brands remain low as the franchise is now available at ~12x FY28 EV/EBITDA. We maintain our FY27/28 EBITDA estimates and our BUY rating with an SOTP-based TP of INR155/sh (implying ~20x FY28 EV/EBITDA).
Financial summary (INR mn)
| Financial | FY25 | FY26E | FY27E | FY28E |
| Net Sales (INR mn) | 78,300 | 83,550 | 94,880 | 1,06,117 |
| Pre-IND AS EBITDA (INR mn) | 5,508 | 6,465 | 8,000 | 9,404 |
| APAT (INR mn) | 1,579 | 1,769 | 3,181 | 4,214 |
| EPS (INR/sh) | 1.3 | 1.4 | 2.6 | 3.5 |
| P/E (x) | 70 | 63 | 35 | 26 |
| EV/EBITDA (x) | 22 | 18 | 13 | 11 |
| EV/Revenue (x) | 2 | 1 | 1 | 1 |
| Pre Ind-AS RoE (ex-goodwill,%) | 14.3 | 10.5 | 12.9 | 12.8 |
| Pre Ind-AS RoIC (ex-goodwill,%) | 11.1 | 10.6 | 12.2 | 13.3 |
| Pre Ind-AS RoCE (ex-goodwill,%)) | 11.4 | 9.7 | 11.5 | 11.9 |
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Disclaimer
The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.
More Markets News
Open Free Demat Account
Open Free Demat Account





By signing up I certify terms, conditions & privacy policy

Join Us
Add as preferred source on Google













